Development and validation of a novel diagnostic nomogram model based on tumor markers for assessing cancer risk of pulmonary lesions: a multicenter study in Chinese population.

•It built the first valid diagnostic nomogram for assessing the cancer risk of the pulmonary lesions.•Tumor size and tumor biomarkers were identified as independent risk factors for lung cancer.•Decision curve analysis reported a net benefit superior to the baseline model.